2012 Fiscal Year Final Research Report
Production of anti-mutated IDH1/2 monoclonal antibodies and its clinical application
Project/Area Number |
23791584
|
Research Category |
Grant-in-Aid for Young Scientists (B)
|
Allocation Type | Multi-year Fund |
Research Field |
Cerebral neurosurgery
|
Research Institution | Yamagata University |
Principal Investigator |
KATO Yukinari 山形大学, 医学部, 非常勤講師 (00571811)
|
Project Period (FY) |
2011 – 2012
|
Keywords | モノクローナル抗体 / グリオーマ / IDH1 / IDH2 / 変異型IDH1/2 / R132H / R132S / 免疫組織染色 |
Research Abstract |
Isocitrate dehydrogenase IDHmutations occur in low-grade gliomas. However, specific mAbs against mutated IDH1 have not been reported. In this study, we established anti-mutated IDH1-specific mAbs HMab-1 and SMab-1, which are useful in immunohistochemistry of glioma.
|
Research Products
(8 results)
-
[Journal Article] Immunohistochemical analysis-based proteomic subclassification of newly diagnosed glioblastomas with integrated genomic and epigenetic profiles2012
Author(s)
Motomura K, Natsume A, Watanabe R, Ito I, Kato Y, Momota H, Nishikawa R, Mishima K, Nakasu Y, Abe T, Namba H, Nakazato Y, Tashiro H, Takeuchi I, Mori T, Wakabayash T
-
Journal Title
Cancer Sci
Volume: 103(10)
Pages: 1871-9
Peer Reviewed
-
[Journal Article] Immunohistochemical detection of IDH1 mutation, p53 and internexin as a prognostic factor of glial tumors2012
Author(s)
Takano S, Kato Y, Yamamoto T, Kaneko MK, Ishikawa E, Tsujimoto Y, Matsuda M, Nakai K, Yanagiya R, Morita S, Tsuboi K, Matsumura A
-
Journal Title
J Neurooncol.
Volume: 108(3)
Pages: 361-73
Peer Reviewed
-
[Journal Article] IDH1 mutation is a favorable prognostic factor for type 2 gliomatosis cerebri2012
Author(s)
Kwon MJ, Kim ST, Kwon MJ, Kong DS, Lee D, Park S, Kang SY, Song JY, Nam DH, Kato Y, Choi YL, Suh YL
-
Journal Title
Brain Pathol
Volume: 22(3)
Pages: 307-317
Peer Reviewed
-
-
-
-
-